These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24338115)

  • 1. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine.
    Friel LA; Czerwinski JL; Singletary CN
    Am J Perinatol; 2014 Oct; 31(9):759-64. PubMed ID: 24338115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of noninvasive prenatal testing at a large academic referral center.
    Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
    Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.
    Li R; Wan J; Zhang Y; Fu F; Ou Y; Jing X; Li J; Li D; Liao C
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):53-7. PubMed ID: 26033469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's views and the impact of noninvasive prenatal testing on procedures in a managed care setting.
    Tiller GE; Kershberg HB; Goff J; Coffeen C; Liao W; Sehnert AJ
    Prenat Diagn; 2015 May; 35(5):428-33. PubMed ID: 25201151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
    Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
    J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening.
    Chetty S; Garabedian MJ; Norton ME
    Prenat Diagn; 2013 Jun; 33(6):542-6. PubMed ID: 23592525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
    Nakata N; Wang Y; Bhatt S
    Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening.
    Petersen OB; Vogel I; Ekelund C; Hyett J; Tabor A; ;
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):265-71. PubMed ID: 24375770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new era in prenatal care: non-invasive prenatal testing in Switzerland.
    Manegold-Brauer G; Kang Bellin A; Hahn S; De Geyter C; Buechel J; Hoesli I; Lapaire O
    Swiss Med Wkly; 2014 Feb; 144():w13915. PubMed ID: 24549748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal non-invasive prenatal test results concordant with karyotype of cytotrophoblast but not reflecting abnormal fetal karyotype.
    Srebniak MI; Diderich KE; Noomen P; Dijkman A; de Vries FA; van Opstal D
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):109-11. PubMed ID: 24585494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of noninvasive prenatal testing as a diagnostic versus a screening tool--a cost-effectiveness analysis.
    Ohno M; Caughey A
    Prenat Diagn; 2013 Jul; 33(7):630-5. PubMed ID: 23674316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States.
    Platt LD; Janicki MB; Prosen T; Goldberg JD; Adashek J; Figueroa R; Rodis J; Liao W; Sehnert AJ; Snyder HL; Warsof SL
    Am J Obstet Gynecol; 2014 Oct; 211(4):368.e1-7. PubMed ID: 24705127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
    Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
    Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
    Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal aneuploidy screening with cell-free DNA in late gestation.
    Taneja PA; Prosen TL; de Feo E; Kruglyak KM; Halks-Miller M; Curnow KJ; Bhatt S
    J Matern Fetal Neonatal Med; 2017 Feb; 30(3):338-342. PubMed ID: 27124739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical implementation of non-invasive prenatal study for detecting aneuploidies by fetal DNA based on single nucleotide polymorphisms: two years in Mexico].
    Sánchez-Usabiaga RA; Aguinaga-Ríos M; Batista-Espinoza A; Hurtado-Amador R; Romero-Tovar S
    Ginecol Obstet Mex; 2015 Apr; 83(4):220-31. PubMed ID: 26727755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester screening and its impact on uptake of diagnostic testing.
    Darnes DR; Hashmi S; Monga M; Sullivan C; Vidaeff A; Berens P; Czerwinski JL
    Prenat Diagn; 2011 Sep; 31(9):892-6. PubMed ID: 21692093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of noninvasive prenatal testing: impact on referrals for diagnostic testing.
    Williams J; Rad S; Beauchamp S; Ratousi D; Subramaniam V; Farivar S; Pisarska MD
    Am J Obstet Gynecol; 2015 Jul; 213(1):102.e1-102.e6. PubMed ID: 25882918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive prenatal detection of aneuploidy.
    Robinson C; van den Boom D; Bombard AT
    Clin Obstet Gynecol; 2014 Mar; 57(1):210-25. PubMed ID: 24351443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.